Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07045337

Enhancing the Therapeutic Effect of Bracing for Adolescent Idiopathic Scoliosis With a Hybrid Bracing Protocol

This is a prospective randomized controlled trial investigating the therapeutic effect of the Hybrid Bracing Protocol (HyBP) over the Conventional Brace in enhancing In-brace Correction (IBC) for adolescent idiopathic scoliosis(AIS).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

10 year–18 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Prince of Wales Hospital

Hong Kong, China

About this study

Scoliosis is a complex three-dimensional spinal deformity and AIS is the commonest with a high prevalence of 2-4%. If left untreated, AIS can progress resulting in significant health problems including back degeneration and negative body images.

Bracing, such as Underarm Brace(UAB) used in our center, is indicated for skeletally immature patients with Cobb angle>20°. Another bracing system is a nighttime Lateral Bending Brace(LBB) designed in a bending position opposite to the convexity of the curve thus resulting in its overcorrection. If AIS becomes severe despite bracing, ultra-major surgery is indicated aiming at bony fusion of the deformed segment with instrumentation. It is therefore important to maximize treatment effectiveness with bracing to control curve progression and to avoid the need for surgery. In-brace Correction(IBC) is the percentage reduction in Cobb angle with bracing.

Studies have reported IBC is an important determinant of brace effectiveness. For enhancement of IBC, we put forward the Hybrid Bracing Protocol(HyBP) combining the use of daytime UAB and nighttime LBB. To be best of our knowledge, HyBP has never been reported in the literature. Our pilot study on 8 patients treated with HyBP and 8 Cobb-matched historical controls treated with fulltime UAB showed very promising results with IBC of 42.1±22.0% and 22.1±14.9% in the HyBP and control group respectively. We therefore propose a formal prospective rater-blinded randomized controlled trial on 120 skeletally immature AIS female subjects with single thoracolumbar or lumbar curve newly prescribed with bracing. They are randomly allocated to the HyBP Group or the Conventional Brace Group (CB Group). The primary objective is to determine if the HyBP Group has better treatment effect in terms of In-brace Correction (IBC) when compared with the CB group at 3-month and 18-month after bracing. This is a 3-year study proposal representing the first phase of a project, to be followed by the second phase of the project when all subjects of the entire cohort will be assessed on curve outcome at time of completion of bracing and at 2 years post-bracing. This study will carry significant clinical impacts in that, if proven useful, the HyBP can be used for enhancement of treatment outcomes with bracing, thus preventing the scoliotic spine from deterioration and to avoid the need for surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females with AIS diagnosed after detailed clinical and radiological evaluation by an experienced orthopaedic surgeon and
  • having a single lumbar or thoracolumbar curve with Cobb angle between 20° - 40° and
  • age 10 years and older when bracing is prescribed and
  • Risser 0 to 2 and
  • either pre-menarchal or less than 1 year post-menarchal and
  • with no prior treatment for scoliosis

Exclusion criteria

  • presenting with associated musculoskeletal, neurological or other conditions possibly responsible for the curvature
  • with previous surgical or orthotic treatment or
  • physical or mental disability that prevent patients from complying with the bracing protocol

Treatment and study plan

Hybrid Bracing

Other

Hybrid Bracing includes daytime Underarm Brace(UAB) and nighttime Lateral Bending Brace(LBB)

Conventional fulltime Underarm Bracing

Other

Conventional group includes fulltime Underarm Brace (UAB) only.

Primary outcomes

  1. In-brace Correction (IBC)

    Time frame: From date of randomization, assessed up to 2 years after bracing stopped at skeletal maturity

    Although bracing is considered to be useful, its effectiveness hinges on various factors one of which is the in-brace curve correction, ie In-brace Correction (IBC). IBC is defined as the percentage of Cobb angle change during an X-ray with the brace fitted on the patient.

Secondary outcomes

  1. Curve progression

    Time frame: From date of randomization, assessed up to 2 years after bracing stopped at skeletal maturity

    To determine if the HyBP has better treatment outcomes in terms of control of curve progression when compared with the conventional fulltime UAB

  2. Quality of life questionnaires

    Time frame: From date of randomization, assessed up to 2 years after bracing stopped at skeletal maturity

    To determine if the HyBP has better outcomes when compared with the conventional fulltime UAB in terms of quality of life as assessed by SRS-22r, Spinal Appearance Questionnaire and the Brace Questionnaire

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

Enhancing the Therapeutic Effect of Bracing for Adolescent Idiopathic Scoliosis With a Hybrid Bracing Protocol: A Randomized-Controlled Trial

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Jul 1, 2025
Registry last updated
Jul 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.